• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

哮喘或 COPD 患者痰液中气道炎症和吸烟状况与 IL-33 水平的关系。

Association of airway inflammation and smoking status with IL-33 level in sputum of patients with asthma or COPD.

机构信息

LungenClinic Grosshansdorf, Airway Research Center North (ARCN), German Center for Lung Research (DZL), Grosshansdorf, Germany.

Authors contributed equally to this work.

出版信息

Eur Respir J. 2024 Sep 26;64(3). doi: 10.1183/13993003.00347-2024. Print 2024 Sep.

DOI:10.1183/13993003.00347-2024
PMID:39147409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11424925/
Abstract

https://bit.ly/3SFspww

摘要

链接

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ea/11424925/5171b15170c6/ERJ-00347-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ea/11424925/5171b15170c6/ERJ-00347-2024.01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ea/11424925/5171b15170c6/ERJ-00347-2024.01.jpg

相似文献

1
Association of airway inflammation and smoking status with IL-33 level in sputum of patients with asthma or COPD.哮喘或 COPD 患者痰液中气道炎症和吸烟状况与 IL-33 水平的关系。
Eur Respir J. 2024 Sep 26;64(3). doi: 10.1183/13993003.00347-2024. Print 2024 Sep.
2
Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype.气道阻塞性疾病中痰液中的白细胞介素-25、白细胞介素-33和胸腺基质淋巴细胞生成素、白细胞介素-23和白细胞介素-36。嗜酸性粒细胞表型中白细胞介素-36水平降低。
Cytokine. 2021 Apr;140:155421. doi: 10.1016/j.cyto.2021.155421. Epub 2021 Jan 22.
3
Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.轻至中度哮喘和慢性阻塞性肺疾病表型中的嗜酸性粒细胞性和中性粒细胞性气道炎症
COPD. 2017 Apr;14(2):181-189. doi: 10.1080/15412555.2016.1260539. Epub 2016 Dec 16.
4
Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者血清、诱导痰上清液及支气管灌洗液中白细胞介素-32的水平
COPD. 2016 Oct;13(5):569-75. doi: 10.3109/15412555.2016.1145201. Epub 2016 Mar 28.
5
Comparative Study of IL-33 and IL-6 Levels in Different Respiratory Samples in Mild-to-Moderate Asthma and COPD.轻度至中度哮喘和慢性阻塞性肺疾病不同呼吸道样本中白细胞介素-33和白细胞介素-6水平的比较研究
COPD. 2018 Feb;15(1):36-45. doi: 10.1080/15412555.2017.1416074. Epub 2018 Jan 10.
6
A comparison of serum and sputum inflammatory mediator profiles in patients with asthma and COPD.哮喘和慢性阻塞性肺疾病患者血清与痰液炎症介质谱的比较
J Int Med Res. 2012;40(6):2231-42. doi: 10.1177/030006051204000621.
7
High mobility group protein B1 (HMGB1) in Asthma: comparison of patients with chronic obstructive pulmonary disease and healthy controls.高迁移率族蛋白 B1（HMGB1）在哮喘中的作用：与慢性阻塞性肺疾病患者和健康对照者的比较。
Mol Med. 2011;17(7-8):807-15. doi: 10.2119/molmed.2010.00173. Epub 2011 Mar 3.
8
The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.稳定期非过敏性 COPD 患者气道嗜酸性粒细胞炎症与 IL-33 的关系。
Respir Res. 2018 Jun 1;19(1):108. doi: 10.1186/s12931-018-0807-y.
9
Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.轻度至中度哮喘和慢性阻塞性肺疾病患者气道炎症的细胞和生化标志物比较：一项诱导痰和支气管肺泡灌洗研究
J Physiol Pharmacol. 2008 Dec;59 Suppl 6:271-83.
10
[Levels of HMGB1 in induced sputum from patients with asthma and chronic obstructive pulmonary disease].[哮喘和慢性阻塞性肺疾病患者诱导痰中高迁移率族蛋白B1水平]
Zhonghua Yi Xue Za Zhi. 2011 Nov 15;91(42):2981-4.

引用本文的文献

1
Established and Emerging Asthma Biomarkers with a Focus on Biologic Trials: A Narrative Review.以生物制剂试验为重点的已确立和新兴哮喘生物标志物：叙述性综述
J Pers Med. 2025 Aug 13;15(8):370. doi: 10.3390/jpm15080370.
2
Anthrahydroquinone-2,6-Disulfonate Restores Lung Function in COPD Through Keap1/Nrf2 Pathway Activation.蒽氢醌-2,6-二磺酸盐通过激活Keap1/Nrf2途径恢复慢性阻塞性肺疾病患者的肺功能。
J Inflamm Res. 2025 Jul 18;18:9559-9579. doi: 10.2147/JIR.S524429. eCollection 2025.
3
Dupilumab and Blood Eosinophilia: A Disease-Specific Phenomenon?

本文引用的文献

1
IL-33 Expression Is Lower in Current Smokers at both Transcriptomic and Protein Levels.IL-33 在转录组和蛋白质水平上在当前吸烟者中的表达均较低。
Am J Respir Crit Care Med. 2023 Nov 15;208(10):1075-1087. doi: 10.1164/rccm.202210-1881OC.
2
Association of Airway Eosinophilia with Small Airway Dysfunction in Patients with Mild and at Risk for COPD.气道嗜酸性粒细胞增多与轻度慢性阻塞性肺疾病（COPD）及高危患者小气道功能障碍的相关性
Int J Chron Obstruct Pulmon Dis. 2022 Jun 17;17:1403-1408. doi: 10.2147/COPD.S366911. eCollection 2022.
3
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial.
度普利尤单抗与血液嗜酸性粒细胞增多：一种疾病特异性现象？
Allergy. 2025 Jun;80(6):1811-1814. doi: 10.1111/all.16610. Epub 2025 Jun 10.
4
ERS Congress 2024: highlights from the Airway Diseases Assembly.2024年欧洲呼吸学会大会：气道疾病研讨会亮点
ERJ Open Res. 2025 Mar 24;11(2). doi: 10.1183/23120541.01255-2024. eCollection 2025 Mar.
5
Integrated analysis reveals that EGR1 promotes epithelial IL33 production in T2 asthma.综合分析表明，EGR1促进2型哮喘中上皮细胞IL33的产生。
J Transl Med. 2025 Feb 18;23(1):203. doi: 10.1186/s12967-025-06116-y.
抗ST2药物阿斯特戈利单抗治疗慢性阻塞性肺疾病（COPD-ST2OP）：一项2a期安慰剂对照试验
Lancet Respir Med. 2022 May;10(5):469-477. doi: 10.1016/S2213-2600(21)00556-7. Epub 2022 Mar 24.
4
Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma.痰液炎症表型对哮喘小气道功能障碍和疾病结局的纵向影响。
J Allergy Clin Immunol Pract. 2022 Jun;10(6):1545-1553.e2. doi: 10.1016/j.jaip.2022.02.020. Epub 2022 Mar 5.
5
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.伊特司珠单抗治疗中重度哮喘的疗效和安全性。
N Engl J Med. 2021 Oct 28;385(18):1656-1668. doi: 10.1056/NEJMoa2024257.
6
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial.特泊替尼治疗中重度 COPD 患者的安全性和有效性：一项遗传关联研究和随机、双盲、2a 期临床试验。
Lancet Respir Med. 2021 Nov;9(11):1288-1298. doi: 10.1016/S2213-2600(21)00167-3. Epub 2021 Jul 21.
7
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.特泽布尔单抗在成人和青少年重症、未控制哮喘中的应用。
N Engl J Med. 2021 May 13;384(19):1800-1809. doi: 10.1056/NEJMoa2034975.
8
The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.稳定期非过敏性 COPD 患者气道嗜酸性粒细胞炎症与 IL-33 的关系。
Respir Res. 2018 Jun 1;19(1):108. doi: 10.1186/s12931-018-0807-y.
9
Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease.哮喘患者气道中 IL-33 和 TSLP 的表达升高：一种潜在的严重难治性疾病的生物标志物。
J Immunol. 2018 Apr 1;200(7):2253-2262. doi: 10.4049/jimmunol.1701455. Epub 2018 Feb 16.
10
Interleukin-33 in health and disease.白细胞介素-33 在健康和疾病中的作用。
Nat Rev Immunol. 2016 Nov;16(11):676-689. doi: 10.1038/nri.2016.95. Epub 2016 Sep 19.